These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17679790)

  • 21. Achieving low-density lipoprotein cholesterol treatment goals among dyslipidemic individuals in the Levant: the CEntralized Pan-Levant survey on tHE Undertreatment of hypercholeSterolemia (CEPHEUS) study.
    Hammoudeh AJ; Echtay A; Ghanem GY; Haddad J;
    Curr Med Res Opin; 2014 Oct; 30(10):1957-65. PubMed ID: 24889279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid target achievement among patients with very high and high cardiovascular risk in a lipid clinic.
    Barkas F; Liberopoulos EN; Kostapanos MS; Liamis G; Tziallas D; Elisaf M
    Angiology; 2015 Apr; 66(4):346-53. PubMed ID: 24830420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.
    Goldberg RB; Mather K
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2077-90. PubMed ID: 22895669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic syndrome revisited: "cardiometabolic risk" emerges as common ground between differing views of the ADA and AHA.
    Stern N; Izkhakov Y
    J Cardiometab Syndr; 2006; 1(5):362-3. PubMed ID: 17679794
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of different metabolic syndrome definitions and risks of incident cardiovascular events in the elderly.
    Vinluan CM; Zreikat HH; Levy JR; Cheang KI
    Metabolism; 2012 Mar; 61(3):302-9. PubMed ID: 21840552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome.
    Koutsovasilis A; Protopsaltis J; Triposkiadis F; Kokkoris S; Milionis HJ; Zairis MN; Skoularigis J; Koukoulis G; Korantzopoulos P; Melidonis A; Foussas SG
    Intern Med; 2009; 48(4):179-87. PubMed ID: 19218766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.
    Robins SJ
    Curr Cardiol Rep; 2005 Nov; 7(6):457-64. PubMed ID: 16256016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the prevalence of the metabolic syndrome using two proposed definitions.
    Ford ES; Giles WH
    Diabetes Care; 2003 Mar; 26(3):575-81. PubMed ID: 12610004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
    Rodrigues CJ; Ribeiro HF; Ribeiro AB; Zanella MT; Batista MC
    Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
    Alberti KG; Eckel RH; Grundy SM; Zimmet PZ; Cleeman JI; Donato KA; Fruchart JC; James WP; Loria CM; Smith SC; ; ; ; ; ;
    Circulation; 2009 Oct; 120(16):1640-5. PubMed ID: 19805654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey.
    Ansell BJ; Fonarow GC; Maki KC; Dicklin MR; Bell M; Davidson MH;
    Am Heart J; 2006 Nov; 152(5):976-81. PubMed ID: 17070174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achievement of national cholesterol education program goals by patients with dyslipidemia in rural ambulatory care settings.
    Qayyum R; Chattha AA; Bhullar N; Katsetos M; Schulman P
    Prev Cardiol; 2006; 9(4):192-7. PubMed ID: 17085980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
    Sirdah MM; Abu Ghali AS; Al Laham NA
    Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.